Steris Plc has seen considerable activity within its investor pool, with several partners reducing and increasing their stock positions including Diversify Advisory Services LLC, Findlay Park Partners LLP, Sumitomo Mitsui Trust Holdings Inc., and Allspring Global Investments Holdings LLC. The performance of Steris Plc's stock has been a mix of outperforming and underperforming competitors on different days, with Q4 2024 earnings calls under scrutiny. Steris has initiated a significant restructuring effort with the proposed sale of its dental segment to HuFriedy Group and the rumored layoffs. The company announced a CEO succession plan and changes to the board. Despite facing challenges in the dental sales sector, Steris experienced strong Q3 Fiscal 2024 results, showing positive revenue and earnings growth. It continues to raise interest among long-term investors and is considered a top growth stock for the long term.
Steris Plc STE News Analytics from Tue, 09 Feb 2016 08:00:00 GMT to Sun, 07 Jul 2024 11:32:21 GMT -
Rating 5
- Innovation 4
- Information 8
- Rumor 2
